Skip to content
Advertisement

This Monday, Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York.  Pfizer said, Tuesday, April 28, 2020,  the COVID-19 pandemic is disrupting its patient testing of experimental drugs and will reduce revenue significantly in the second quarter, but its manufacturing plants are running normally. (AP Photo/Richard Drew, File)

This Monday, Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer said, Tuesday, April 28, 2020, the COVID-19 pandemic is disrupting its patient testing of experimental drugs and will reduce revenue significantly in the second quarter, but its manufacturing plants are running normally. (AP Photo/Richard Drew, File)

Featured Photo Galleries